Riskpilot← Back to searchSign inGet full accessBioXpedia A/S
A/SBankruptCVR 38281860Palle Juul-Jensens Boulevard 82Research and experimental development on natural sciences and engineering · NACE 7210Est. 201617 employeeswww.bioxpedia.com
Revenue 2023
DKK 9M
+1% vs 2022
EBITDA margin
-3.2%
-122% vs 2022
Equity ratio
-22.6%
Financial strength
Net profit 2023
DKK -1,2M
-2633% vs 2022
| Revenue | DKK 9M | +1% |
| EBITDA | DKK -283K | -122% |
| Net profit | DKK -1,2M | -2633% |
| Total assets | DKK 17,5M | +143% |
| Equity | DKK -3,9M | -45% |
| Employees | 17 | — |
Legal name
BioXpedia A/S
CVR number
38281860
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23. december 2016
Share capital
DKK 500.000
Employees
17 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive laboratorievirksomhed samt enhver anden aktivitet der efter bestyrelsens skøn er forbundet hermed.
Address
Palle Juul-Jensens Boulevard 82
Email
mkruhoffer@bioxpedia.com
Website
www.bioxpedia.com
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | 253 | 1.895 | 3.529 | 5.400 | 4.948 | 8.913 | 8.980 |
| Staff expenses | -746 | -1.647 | -2.918 | -5.700 | -6.518 | -7.625 | -9.263 |
| EBITDA | -493 | 248 | 611 | -300 | -1.570 | 1.288 | -283 |
| Depreciation & amort. | -171 | -323 | -385 | -758 | -1.049 | -999 | -1.026 |
| EBIT | -665 | -75 | 226 | -1.057 | -2.619 | 290 | -1.309 |
| Net financials | -39 | -105 | -100 | -176 | -199 | -220 | -257 |
| Profit before tax | -704 | -180 | 125 | -1.234 | -2.818 | 70 | -1.566 |
| Tax | -150 | -37 | 30 | -269 | -619 | 21 | -333 |
| Net profit | -554 | -143 | 96 | -965 | -2.199 | 49 | -1.233 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Total assets | 2.000 | 3.228 | 5.220 | 5.593 | 5.799 | 7.213 | 17.503 |
| Equity | -54 | 303 | 399 | -566 | -2.765 | -2.717 | -3.949 |
| Long-term debt | 822 | 851 | 643 | 1.485 | 1.233 | 1.180 | 8.404 |
| Short-term debt | 1.232 | 2.074 | 4.178 | 4.674 | 7.331 | 8.750 | 13.048 |
| Total debt | 2.054 | 2.924 | 4.821 | 6.159 | 8.565 | 9.930 | 21.452 |
EBITDA margin
-3.2%
This company
15.8%
Market median
-120% vs market
20172023
Equity ratio
-22.6%
This company
38.2%
Market median
-159% vs market
20172023
Return on equity
-123262300.0%
This company
18.4%
Market median
-669903904% vs market
20172023
Net profit margin
-13.7%
This company
8.1%
Market median
-269% vs market
20172023
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20172023
Debt / equity
5.43×
This company
0.62×
Market median
-776% vs market
20172023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2016-12-23 – 2017-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2016 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2023 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
HMK CONSULT ApS | Company | 100.0% | 100.0% | 2016 |
| Individual | 100.0% | 100.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HMK CONSULT ApS
BioXpedia A/S Board members of BioXpedia A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mads Aaboe Jensen | Board of Directors | 0 companies |
| Brian Sørensen | Chairman | 0 companies |
| Lars Dyrskjøt Andersen | Chairman | 0 companies |
| Peter Reeslev | Chairman | 0 companies |
| Niels Christian Buur | Chairman | 0 companies |
| Niels Stampe Rüdiger | Board of Directors | 0 companies |